United States· US:0019-4816_79425e73-456a-458a-986d-baf4291584a2

MD GASTROVIEW

A medicinal product containing diatrizoate meglumine; diatrizoate sodium, registered in United States by Liebel-Flarsheim Company LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMD GASTROVIEWATC—REGISTER NO.US:0019-4816_79425e73…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Manufacturer
Liebel-Flarsheim Company LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0019481604
    25 BOTTLE, GLASS in 1 BOX (0019-4816-04) / 30 mL in 1 BOTTLE, GLASS
  • ndc11
    0019-4816-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diatrizoate meglumine; diatrizoate sodium in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diatrizoate meglumine; diatrizoate sodium products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Gastrografin
  • Bulgaria · Урографин
  • Germany · Gastrografin, Gastrolux
  • Spain · Amidotrizoato De Sodio Y Amidotrizoato De Meglumina Iberoinvesa Pharma, Gastrografin
  • Finland · Gastrografin
  • France · Gastrografine, Radioselectan Urinaire
  • United Kingdom (Northern Ireland) · Gastrografin, Urografin 150
  • Croatia · Gastrografin
  • Hungary · Gastrografin
  • Ireland · Gastrografin, Urografin
  • Italy · Gastrografin
  • Lithuania · Urografin
  • Latvia · Urografin
  • Netherlands · Gastrografin, Urografin
  • Norway · Gastrografin
  • Poland · Gastrografin
  • Portugal · Gastrografina, Urografina
  • Sweden · Gastrografin
  • Slovakia · Urografin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45bcdcf9-2712-438b-883c-4e62d548ba32
GET /v1/drugs/45bcdcf9-2712-438b-883c-4e62d548ba32?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL; RECTAL",
  "source": "ndc",
  "strength": "600; 100",
  "substance": "DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM",
  "productndc": "0019-4816",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL; mg/mL",
  "application_number": "ANDA087388",
  "marketing_category": "ANDA"
}

See everything about diatrizoate meglumine; diatrizoate sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.